LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer

Neoplasia

Volumn 11, Issue 7, 2009, Pages 712-719

  Nakata, Kohei ^a   Ohuchida, Kenoki ^a   Nagai, Eishi ^a   Hayashi, Akifumi ^a   Miyasaka, Yoshihiro ^a   Kayashima, Tadashi ^a   Yu, Jun ^a   Aishima, Shinichi ^a   Oda, Yoshinao ^a   Mizumoto, Kazuhiro ^a   Tanaka, Masao ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CARCINOMA CELL; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; LIM DOMAIN ONLY 2 GENE; MAJOR CLINICAL STUDY; MALE; MICRODISSECTION; ONCOGENE; PANCREAS CANCER; PANCREAS CARCINOMA IN SITU; PANCREAS DUCT; PANCREAS SURGERY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 67650501096     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09418     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, and Thun MJ (2008). Cancer statistics, 2008. CA Cancer J Clin 58, 71-96.
2. Warshaw AL and Fernandez-del Castillo C (1992). Pancreatic carcinoma. N Engl J Med 326, 455-465.
3. Niederhuber JE, Brennan MF, and Menck HR (1995). The National Cancer Data Base report on pancreatic cancer. Cancer 76, 1671-1677.
4. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, and Farnell MB (2008). Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247, 456-462.
5. Singh RR, Barnes CJ, Talukder AH, Fuqua SA, and Kumar R (2005). Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. Cancer Res 65, 10594-10601.
6. Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL, Lindeman GJ, and Visvader JE (2005). Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc Natl Acad Sci USA 102, 7659-7664.
7. Nam CH and Rabbitts TH (2006). The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion. Mol Ther 13, 15-25.
8. Boehm T, Baer R, Lavenir I, Forster A, Waters JJ, Nacheva E, and Rabbitts TH (1988). The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J 7, 385-394.
9. Boehm T, Foroni L, Kaneko Y, Perutz MF, and Rabbitts TH (1991). The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci USA 88, 4367-4371.
10. Foroni L, Boehm T, White L, Forster A, Sherrington P, Liao XB, Brannan CI, Jenkins NA, Copeland NG, and Rabbitts TH (1992). The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. J Mol Biol 226, 747-761.
11. Natkunam Y, Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton Dutoit S, Lossos IS, and Levy R (2007). The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 109, 1636-1642.
12. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, and Levy R (2004). Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350, 1828-1837.
13. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Kloppel G, Longnecker DS, et al. (2001). Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25, 579-586.
14. Sobin LH and Greene FL (2001). TNM classification: clarification of number of regional lymph nodes for pN0. Cancer 92, 452.
15. Hamilton SR (2000). World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Digestive System. Lyon, France: IARC.
16. Japan Pancreas Society (1996). Classification of Pancreatic Carcinoma. 1st English ed. Tokyo, Japan: Kanehara & Company, Ltd.
17. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, and Tsao MS (1996). Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 148, 1763-1770.
18. Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, Nagai E, Matsumoto K, Nakamura T, and Tanaka M (2004). Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64, 3215-3222.
19. Tachikawa T and Irie T (2004). A new molecular biology approach in morphology: basic method and application of laser microdissection. Med Electron Microsc 37, 82-88.
20. Ma S, Guan XY, Beh PS, Wong KY, Chan YP, Yuen HF, Vielkind J, and Chan KW (2007). The significance of LMO2 expression in the progression of prostate cancer. J Pathol 211, 278-285.
21. Buchholz M, Braun M, Heidenblut A, Kestler HA, Kloppel G, Schmiegel W, Hahn SA, Luttges J, and Gress TM (2005). Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24, 6626-6636.
22. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511.
23. Reddy SK, Tyler DS, Pappas TN, and Clary BM (2007). Extended resection for pancreatic adenocarcinoma. Oncologist 12, 654-663.
24. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, and Tanaka M (2007). Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer 120, 1634-1640.